ARTICLE | Product Development
Will Biocon’s COVID-19 anti-inflammatory succeed where IL-6 blockers have failed?
Biocon is ramping up manufacturing of Alzumab as it prepares to start a large study of the drug
August 1, 2020 12:45 AM UTC
Updated on Aug 12, 2020 at 9:47 PM UTC
BCIQ Company Profiles